Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain

This open-label study evaluated the long-term safety and tolerability of oral transmucosal fentanyl citrate (OTFC) in ambulatory cancer patients with breakthrough pain undergoing cancer care at 32 university- or community-based practices. Patients had participated in a previous short-term titration...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of pain and symptom management 2001-07, Vol.22 (1), p.575-583
Hauptverfasser:	Payne, Richard, Coluzzi, Paul, Hart, Lowell, Simmonds, Mary, Lyss, Alan, Rauck, Richard, Berris, Robert, Busch, Michael A, Nordbrook, Earl, Loseth, Diane B, Portenoy, Russell K
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Aged, 80 and over Ambulatory Care Analgesics Analgesics, Opioid - administration & dosage Analgesics, Opioid - therapeutic use Biological and medical sciences cancer pain Female Fentanyl - administration & dosage Fentanyl - therapeutic use Humans long-term therapy Male Medical sciences Middle Aged Neoplasms - complications Neuropharmacology Oral transmucosal fentanyl Pain - drug therapy Pain - etiology Patient Satisfaction Pharmacology. Drug treatments side effects Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!